Table 1.

Clinical trials involving the use of Anakinra and Ilaris for the treatment of different cancer types.

Treatment	Cancer type	Clinical trial identifier	Clinical trial phase
Anakinra and standard of care	Metastatic breast cancer	Nbib1802970	Phase I
Anakinra and Bevacizumab	Metastatic colorectal cancer	Nbib2090101	Phase II
Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra	Pancreatic adenocarcinoma	Nbib2550327	Early Phase I
Anakinra alone or with Dexamethasone	Multiple myeloma	Nbib635154	Phase II
	Plasma cell neoplasm
Anakinra or Denosumab and Everolimus	Advanced cancers	Nbib1624766	Phase I
Lenalidomide and Dexamethasone with or without Anakinra	Indolent plasma cell myeloma	Nbib2492750	Phase I, followed by Phase II
	Plasma cell myeloma
	Smoldering plasma cell myeloma
PDR001 in combination with CJM112, EGF816, Ilaris (Canakinumab) or Mekinist (Trametinib)	Colorectal cancer, triple-negative breast cancer, NSCLC, adenocarcinoma	Nbib2900664	Phase I